Summary
UNITEDHEALTH GROUP INC. (UNH) reported its 2025 fiscal year results, highlighting continued revenue growth across its segments, particularly in UnitedHealthcare and Optum Rx. Despite a strong top-line performance, the company's earnings from operations saw a significant decline of 41% compared to the prior year. This decrease was primarily attributed to elevated medical cost trends, which outpaced pricing assumptions, and the impact of restructuring and other actions totaling $2.5 billion. Key areas impacting profitability include increased medical costs driven by higher care activity, provider pricing, and the effects of the Inflation Reduction Act on Medicare Part D plans. UnitedHealthcare experienced a 16% revenue increase, driven by Medicare Advantage and fee-based commercial offerings, but its earnings from operations fell by 40% due to the aforementioned cost pressures and specific business adjustments. Optum, while growing revenues by 7%, saw its earnings from operations decrease by 43%, largely due to challenges within Optum Health, which reported a net loss from operations. This segment was impacted by Medicare Advantage funding reductions and medical cost trends. Optum Rx, however, demonstrated strong performance with a 16% revenue increase and a 23% rise in earnings from operations, benefiting from higher script volumes and a gain on a business deconsolidation. The company also managed its capital effectively, with significant cash flows from operations and a robust balance sheet, while continuing to return capital to shareholders through dividends and share repurchases.
Financial Highlights
56 data points| Revenue | $447.57B |
| Cost of Revenue | $50.66B |
| Gross Profit | $396.91B |
| SG&A Expenses | $59.59B |
| Operating Expenses | $428.60B |
| Operating Income | $18.96B |
| Interest Expense | $4.00B |
| Net Income | $12.06B |
| EPS (Basic) | $13.28 |
| EPS (Diluted) | $13.23 |
| Shares Outstanding (Basic) | 908.00M |
| Shares Outstanding (Diluted) | 911.00M |
Key Highlights
- 1Total revenues increased by 12% to $447.6 billion, driven by strong performance in UnitedHealthcare (+16%) and Optum Rx (+16%).
- 2Earnings from operations decreased significantly by 41% to $19.0 billion, primarily due to elevated medical cost trends and restructuring charges.
- 3UnitedHealthcare segment saw revenue growth of 16% but a 40% decline in earnings from operations, impacted by medical cost pressures and Medicare Advantage funding.
- 4Optum Health reported a net loss from operations (-$0.3 billion) and a significant decline in operating margin, affected by Medicare funding reductions and increased medical costs.
- 5Optum Rx showed robust growth, with revenues up 16% and earnings from operations up 23%, benefiting from increased script volumes and portfolio gains.
- 6The company provided substantial support to care providers impacted by the Change Healthcare cyberattack, including increasing reserves for provider loans by $799 million.
- 7UnitedHealth Group continues to return capital to shareholders, increasing its quarterly cash dividend and maintaining its share repurchase program, with $21 million shares remaining available for repurchase as of December 31, 2025.